NSCLC cells were treated with non-targeting control siRNA and Fas, DR3, DR4, DR5, DR6 siRNA (100 nM) for 24 h, and then were treated with PL (10 μM) for another 24 h. The gene discussed is TNFRSF10A; the disease is non-small cell lung carcinoma.